Nutriband Inc. (NASDAQ: NTRBW) Stock Competitors & Peer Comparison

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, VRTX has a market cap of 132.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while VRTX trades at $521.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas VRTX's P/E ratio is 27.38. In terms of profitability, NTRBW's ROE is -1.09%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, NTRBW is more volatile compared to VRTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check VRTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, REGN has a market cap of 83.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while REGN trades at $807.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas REGN's P/E ratio is 17.70. In terms of profitability, NTRBW's ROE is -1.09%, compared to REGN's ROE of +0.14%. Regarding short-term risk, NTRBW is more volatile compared to REGN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check REGN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while VRNA trades at $106.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas VRNA's P/E ratio is -102.80. In terms of profitability, NTRBW's ROE is -1.09%, compared to VRNA's ROE of -0.02%. Regarding short-term risk, NTRBW is more volatile compared to VRNA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check VRNA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ARGX has a market cap of 62.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ARGX trades at $1,002.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ARGX's P/E ratio is 90.46. In terms of profitability, NTRBW's ROE is -1.09%, compared to ARGX's ROE of +0.24%. Regarding short-term risk, NTRBW is more volatile compared to ARGX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ARGX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MRNA has a market cap of 53.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MRNA trades at $135.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MRNA's P/E ratio is -16.64. In terms of profitability, NTRBW's ROE is -1.09%, compared to MRNA's ROE of -0.39%. Regarding short-term risk, NTRBW is more volatile compared to MRNA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MRNA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RVMDW has a market cap of 46B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RVMDW trades at $11.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RVMDW's P/E ratio is -1.33. In terms of profitability, NTRBW's ROE is -1.09%, compared to RVMDW's ROE of -0.96%. Regarding short-term risk, NTRBW is more volatile compared to RVMDW. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RVMDW's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RVMD has a market cap of 44.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RVMD trades at $207.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RVMD's P/E ratio is -23.55. In terms of profitability, NTRBW's ROE is -1.09%, compared to RVMD's ROE of -0.96%. Regarding short-term risk, NTRBW is more volatile compared to RVMD. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RVMD's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while SGEN trades at $228.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas SGEN's P/E ratio is -57.19. In terms of profitability, NTRBW's ROE is -1.09%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, NTRBW is more volatile compared to SGEN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check SGEN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ONC has a market cap of 37.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ONC trades at $351.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ONC's P/E ratio is 61.80. In terms of profitability, NTRBW's ROE is -1.09%, compared to ONC's ROE of +0.14%. Regarding short-term risk, NTRBW is more volatile compared to ONC. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ONC's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ALNY has a market cap of 34.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ALNY trades at $258.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ALNY's P/E ratio is 46.49. In terms of profitability, NTRBW's ROE is -1.09%, compared to ALNY's ROE of +0.94%. Regarding short-term risk, NTRBW is more volatile compared to ALNY. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ALNY's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ROIV has a market cap of 30.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ROIV trades at $41.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ROIV's P/E ratio is -39.78. In terms of profitability, NTRBW's ROE is -1.09%, compared to ROIV's ROE of -0.06%. Regarding short-term risk, NTRBW is more volatile compared to ROIV. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ROIV's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, INSM has a market cap of 27.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while INSM trades at $128.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas INSM's P/E ratio is -31.34. In terms of profitability, NTRBW's ROE is -1.09%, compared to INSM's ROE of -1.11%. Regarding short-term risk, NTRBW is more volatile compared to INSM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check INSM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, INCY has a market cap of 25.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while INCY trades at $126.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas INCY's P/E ratio is 16.94. In terms of profitability, NTRBW's ROE is -1.09%, compared to INCY's ROE of +0.30%. Regarding short-term risk, NTRBW is more volatile compared to INCY. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check INCY's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BNTX has a market cap of 24.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BNTX trades at $98.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BNTX's P/E ratio is -12.73. In terms of profitability, NTRBW's ROE is -1.09%, compared to BNTX's ROE of -0.09%. Regarding short-term risk, NTRBW is more volatile compared to BNTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BNTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, UTHR has a market cap of 21.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while UTHR trades at $506.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas UTHR's P/E ratio is 18.13. In terms of profitability, NTRBW's ROE is -1.09%, compared to UTHR's ROE of +0.20%. Regarding short-term risk, NTRBW is more volatile compared to UTHR. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check UTHR's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, GMAB has a market cap of 20.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while GMAB trades at $33.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas GMAB's P/E ratio is 24.90. In terms of profitability, NTRBW's ROE is -1.09%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, NTRBW is more volatile compared to GMAB. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check GMAB's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BGNE trades at $184.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BGNE's P/E ratio is -22.55. In terms of profitability, NTRBW's ROE is -1.09%, compared to BGNE's ROE of +0.14%. Regarding short-term risk, NTRBW is more volatile compared to BGNE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BGNE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while DNA-WT trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, NTRBW's ROE is -1.09%, compared to DNA-WT's ROE of -0.60%. Regarding short-term risk, NTRBW is more volatile compared to DNA-WT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check DNA-WT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ASND has a market cap of 16.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ASND trades at $260.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ASND's P/E ratio is -107.77. In terms of profitability, NTRBW's ROE is -1.09%, compared to ASND's ROE of +1.90%. Regarding short-term risk, NTRBW is more volatile compared to ASND. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ASND's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, NBIX has a market cap of 15.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while NBIX trades at $155.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas NBIX's P/E ratio is 22.42. In terms of profitability, NTRBW's ROE is -1.09%, compared to NBIX's ROE of +0.21%. Regarding short-term risk, NTRBW is more volatile compared to NBIX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check NBIX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, JAZZ has a market cap of 15.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while JAZZ trades at $241.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas JAZZ's P/E ratio is 9.00. In terms of profitability, NTRBW's ROE is -1.09%, compared to JAZZ's ROE of +0.21%. Regarding short-term risk, NTRBW is more volatile compared to JAZZ. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check JAZZ's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BBIO has a market cap of 14.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BBIO trades at $76.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BBIO's P/E ratio is -20.34. In terms of profitability, NTRBW's ROE is -1.09%, compared to BBIO's ROE of +0.32%. Regarding short-term risk, NTRBW is more volatile compared to BBIO. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BBIO's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, EXEL has a market cap of 14.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while EXEL trades at $58.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas EXEL's P/E ratio is 16.67. In terms of profitability, NTRBW's ROE is -1.09%, compared to EXEL's ROE of +0.42%. Regarding short-term risk, NTRBW is more volatile compared to EXEL. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check EXEL's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, SMMT has a market cap of 14B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while SMMT trades at $17.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas SMMT's P/E ratio is -15.66. In terms of profitability, NTRBW's ROE is -1.09%, compared to SMMT's ROE of -2.04%. Regarding short-term risk, NTRBW is more volatile compared to SMMT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check SMMT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, HALO has a market cap of 12.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while HALO trades at $107.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas HALO's P/E ratio is 20.04. In terms of profitability, NTRBW's ROE is -1.09%, compared to HALO's ROE of +1.81%. Regarding short-term risk, NTRBW is more volatile compared to HALO. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check HALO's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MDGL has a market cap of 12.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MDGL trades at $546.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MDGL's P/E ratio is -42.71. In terms of profitability, NTRBW's ROE is -1.09%, compared to MDGL's ROE of -0.57%. Regarding short-term risk, NTRBW is more volatile compared to MDGL. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MDGL's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while KRTX trades at $329.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas KRTX's P/E ratio is -28.09. In terms of profitability, NTRBW's ROE is -1.09%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, NTRBW is more volatile compared to KRTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check KRTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BMRN has a market cap of 12.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BMRN trades at $64.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BMRN's P/E ratio is 30.97. In terms of profitability, NTRBW's ROE is -1.09%, compared to BMRN's ROE of +0.01%. Regarding short-term risk, NTRBW is more volatile compared to BMRN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BMRN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ARWR has a market cap of 11.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ARWR trades at $82.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ARWR's P/E ratio is -36.72. In terms of profitability, NTRBW's ROE is -1.09%, compared to ARWR's ROE of -0.61%. Regarding short-term risk, NTRBW is more volatile compared to ARWR. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ARWR's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TECH has a market cap of 11.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TECH trades at $72.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TECH's P/E ratio is 37.24. In terms of profitability, NTRBW's ROE is -1.09%, compared to TECH's ROE of +0.09%. Regarding short-term risk, NTRBW is more volatile compared to TECH. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TECH's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RNAM trades at $72.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RNAM's P/E ratio is -17.39. In terms of profitability, NTRBW's ROE is -1.09%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, NTRBW is more volatile compared to RNAM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RNAM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, AXSM has a market cap of 10.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while AXSM trades at $210.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas AXSM's P/E ratio is -54.99. In terms of profitability, NTRBW's ROE is -1.09%, compared to AXSM's ROE of -2.56%. Regarding short-term risk, NTRBW is more volatile compared to AXSM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check AXSM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, KRYS has a market cap of 10.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while KRYS trades at $348.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas KRYS's P/E ratio is 43.62. In terms of profitability, NTRBW's ROE is -1.09%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, NTRBW is more volatile compared to KRYS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check KRYS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PRAX has a market cap of 9.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PRAX trades at $345.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PRAX's P/E ratio is -26.71. In terms of profitability, NTRBW's ROE is -1.09%, compared to PRAX's ROE of -0.34%. Regarding short-term risk, NTRBW is more volatile compared to PRAX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PRAX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RXDX trades at $199.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RXDX's P/E ratio is -56.47. In terms of profitability, NTRBW's ROE is -1.09%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, NTRBW is more volatile compared to RXDX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RXDX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, KYMR has a market cap of 9.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while KYMR trades at $115.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas KYMR's P/E ratio is -36.07. In terms of profitability, NTRBW's ROE is -1.09%, compared to KYMR's ROE of -0.22%. Regarding short-term risk, NTRBW is more volatile compared to KYMR. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check KYMR's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PTGX has a market cap of 9.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PTGX trades at $145.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PTGX's P/E ratio is 140.86. In terms of profitability, NTRBW's ROE is -1.09%, compared to PTGX's ROE of +0.12%. Regarding short-term risk, NTRBW is more volatile compared to PTGX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PTGX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, IONS has a market cap of 9.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while IONS trades at $56.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas IONS's P/E ratio is -32.57. In terms of profitability, NTRBW's ROE is -1.09%, compared to IONS's ROE of -1.11%. Regarding short-term risk, NTRBW is more volatile compared to IONS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check IONS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CYTK has a market cap of 9.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CYTK trades at $74.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CYTK's P/E ratio is -10.26. In terms of profitability, NTRBW's ROE is -1.09%, compared to CYTK's ROE of +1.64%. Regarding short-term risk, NTRBW is more volatile compared to CYTK. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CYTK's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, NUVL has a market cap of 9.1B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while NUVL trades at $123.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas NUVL's P/E ratio is -21.79. In terms of profitability, NTRBW's ROE is -1.09%, compared to NUVL's ROE of -0.43%. Regarding short-term risk, NTRBW is more volatile compared to NUVL. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check NUVL's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CRNX has a market cap of 9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CRNX trades at $84.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CRNX's P/E ratio is -16.86. In terms of profitability, NTRBW's ROE is -1.09%, compared to CRNX's ROE of -0.44%. Regarding short-term risk, NTRBW is more volatile compared to CRNX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CRNX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ABVX has a market cap of 8.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ABVX trades at $119.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ABVX's P/E ratio is -62.62. In terms of profitability, NTRBW's ROE is -1.09%, compared to ABVX's ROE of -1.65%. Regarding short-term risk, NTRBW is more volatile compared to ABVX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ABVX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while IMGN trades at $31.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas IMGN's P/E ratio is -111.55. In terms of profitability, NTRBW's ROE is -1.09%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, NTRBW is more volatile compared to IMGN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check IMGN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PCVX has a market cap of 8.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PCVX trades at $59.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PCVX's P/E ratio is -7.80. In terms of profitability, NTRBW's ROE is -1.09%, compared to PCVX's ROE of -0.38%. Regarding short-term risk, NTRBW is more volatile compared to PCVX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PCVX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TXG has a market cap of 8.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TXG trades at $67.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TXG's P/E ratio is -114.05. In terms of profitability, NTRBW's ROE is -1.09%, compared to TXG's ROE of -0.09%. Regarding short-term risk, NTRBW is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TXG's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, IBRX has a market cap of 8.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while IBRX trades at $8.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas IBRX's P/E ratio is -8.31. In terms of profitability, NTRBW's ROE is -1.09%, compared to IBRX's ROE of +1.35%. Regarding short-term risk, NTRBW is more volatile compared to IBRX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check IBRX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TGTX has a market cap of 8.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TGTX trades at $54.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TGTX's P/E ratio is 19.80. In terms of profitability, NTRBW's ROE is -1.09%, compared to TGTX's ROE of +0.72%. Regarding short-term risk, NTRBW is more volatile compared to TGTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TGTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BPMC trades at $129.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BPMC's P/E ratio is -51.58. In terms of profitability, NTRBW's ROE is -1.09%, compared to BPMC's ROE of -0.31%. Regarding short-term risk, NTRBW is more volatile compared to BPMC. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BPMC's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, APGE has a market cap of 8.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while APGE trades at $135.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas APGE's P/E ratio is -31.19. In terms of profitability, NTRBW's ROE is -1.09%, compared to APGE's ROE of -0.30%. Regarding short-term risk, NTRBW is more volatile compared to APGE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check APGE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CERE trades at $44.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CERE's P/E ratio is -16.47. In terms of profitability, NTRBW's ROE is -1.09%, compared to CERE's ROE of -0.72%. Regarding short-term risk, NTRBW is more volatile compared to CERE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CERE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, IMVT has a market cap of 8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while IMVT trades at $38.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas IMVT's P/E ratio is -13.74. In terms of profitability, NTRBW's ROE is -1.09%, compared to IMVT's ROE of -0.70%. Regarding short-term risk, NTRBW is more volatile compared to IMVT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check IMVT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TWST has a market cap of 7.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TWST trades at $125.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TWST's P/E ratio is -56.54. In terms of profitability, NTRBW's ROE is -1.09%, compared to TWST's ROE of -0.30%. Regarding short-term risk, NTRBW is more volatile compared to TWST. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TWST's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, SYRE has a market cap of 7.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while SYRE trades at $86.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas SYRE's P/E ratio is -44.58. In terms of profitability, NTRBW's ROE is -1.09%, compared to SYRE's ROE of -0.24%. Regarding short-term risk, NTRBW is more volatile compared to SYRE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check SYRE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MTSR trades at $70.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MTSR's P/E ratio is -23.58. In terms of profitability, NTRBW's ROE is -1.09%, compared to MTSR's ROE of -0.61%. Regarding short-term risk, NTRBW is more volatile compared to MTSR. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MTSR's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, BLTE has a market cap of 7.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while BLTE trades at $183.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas BLTE's P/E ratio is -97.95. In terms of profitability, NTRBW's ROE is -1.09%, compared to BLTE's ROE of -0.16%. Regarding short-term risk, NTRBW is more volatile compared to BLTE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check BLTE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RYTM has a market cap of 6.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RYTM trades at $101.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RYTM's P/E ratio is -32.50. In terms of profitability, NTRBW's ROE is -1.09%, compared to RYTM's ROE of -0.80%. Regarding short-term risk, NTRBW is more volatile compared to RYTM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RYTM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MRUS trades at $90.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MRUS's P/E ratio is -17.05. In terms of profitability, NTRBW's ROE is -1.09%, compared to MRUS's ROE of -0.46%. Regarding short-term risk, NTRBW is more volatile compared to MRUS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MRUS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CAI has a market cap of 6.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CAI trades at $24.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CAI's P/E ratio is 67.52. In terms of profitability, NTRBW's ROE is -1.09%, compared to CAI's ROE of +0.19%. Regarding short-term risk, NTRBW is more volatile compared to CAI. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CAI's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ACLX trades at $115.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ACLX's P/E ratio is -28.27. In terms of profitability, NTRBW's ROE is -1.09%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, NTRBW is more volatile compared to ACLX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ACLX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RETA trades at $172.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RETA's P/E ratio is -66.29. In terms of profitability, NTRBW's ROE is -1.09%, compared to RETA's ROE of +0.47%. Regarding short-term risk, NTRBW is more volatile compared to RETA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RETA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, SRRK has a market cap of 6.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while SRRK trades at $54.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas SRRK's P/E ratio is -15.83. In terms of profitability, NTRBW's ROE is -1.09%, compared to SRRK's ROE of -1.60%. Regarding short-term risk, NTRBW is more volatile compared to SRRK. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check SRRK's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CGON has a market cap of 6.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CGON trades at $71.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CGON's P/E ratio is -26.75. In terms of profitability, NTRBW's ROE is -1.09%, compared to CGON's ROE of -0.25%. Regarding short-term risk, NTRBW is more volatile compared to CGON. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CGON's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CNTA has a market cap of 6.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CNTA trades at $40.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CNTA's P/E ratio is -22.63. In terms of profitability, NTRBW's ROE is -1.09%, compared to CNTA's ROE of -0.60%. Regarding short-term risk, NTRBW is more volatile compared to CNTA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CNTA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TVTX has a market cap of 6.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TVTX trades at $66.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TVTX's P/E ratio is -147.16. In terms of profitability, NTRBW's ROE is -1.09%, compared to TVTX's ROE of -0.56%. Regarding short-term risk, NTRBW is more volatile compared to TVTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TVTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MIRM has a market cap of 6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MIRM trades at $98.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MIRM's P/E ratio is -6.76. In terms of profitability, NTRBW's ROE is -1.09%, compared to MIRM's ROE of -4.10%. Regarding short-term risk, NTRBW is more volatile compared to MIRM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MIRM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, DNTH has a market cap of 6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while DNTH trades at $107.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas DNTH's P/E ratio is -25.79. In terms of profitability, NTRBW's ROE is -1.09%, compared to DNTH's ROE of -0.04%. Regarding short-term risk, NTRBW is more volatile compared to DNTH. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check DNTH's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, COGT has a market cap of 5.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while COGT trades at $34.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas COGT's P/E ratio is -16.20. In terms of profitability, NTRBW's ROE is -1.09%, compared to COGT's ROE of -0.73%. Regarding short-term risk, NTRBW is more volatile compared to COGT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check COGT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, LGND has a market cap of 5.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while LGND trades at $288.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas LGND's P/E ratio is 31.62. In terms of profitability, NTRBW's ROE is -1.09%, compared to LGND's ROE of +0.20%. Regarding short-term risk, NTRBW is more volatile compared to LGND. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check LGND's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, XENE has a market cap of 5.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while XENE trades at $58.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas XENE's P/E ratio is -12.55. In terms of profitability, NTRBW's ROE is -1.09%, compared to XENE's ROE of -0.44%. Regarding short-term risk, NTRBW is more volatile compared to XENE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check XENE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PTCT has a market cap of 5.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PTCT trades at $67.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PTCT's P/E ratio is -29.00. In terms of profitability, NTRBW's ROE is -1.09%, compared to PTCT's ROE of +0.22%. Regarding short-term risk, NTRBW is more volatile compared to PTCT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PTCT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CDTX trades at $221.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CDTX's P/E ratio is -19.77. In terms of profitability, NTRBW's ROE is -1.09%, compared to CDTX's ROE of -0.37%. Regarding short-term risk, NTRBW is more volatile compared to CDTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CDTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ABCM trades at $23.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, NTRBW's ROE is -1.09%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, NTRBW is more volatile compared to ABCM. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ABCM's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ORKA has a market cap of 5.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ORKA trades at $91.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ORKA's P/E ratio is -47.16. In terms of profitability, NTRBW's ROE is -1.09%, compared to ORKA's ROE of -0.21%. Regarding short-term risk, NTRBW is more volatile compared to ORKA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ORKA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ISEE trades at $39.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ISEE's P/E ratio is -22.44. In terms of profitability, NTRBW's ROE is -1.09%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, NTRBW is more volatile compared to ISEE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ISEE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ERAS has a market cap of 5.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ERAS trades at $15.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ERAS's P/E ratio is -16.88. In terms of profitability, NTRBW's ROE is -1.09%, compared to ERAS's ROE of -0.80%. Regarding short-term risk, NTRBW is more volatile compared to ERAS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ERAS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, APLS has a market cap of 5.3B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while APLS trades at $41.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas APLS's P/E ratio is 38.35. In terms of profitability, NTRBW's ROE is -1.09%, compared to APLS's ROE of +0.40%. Regarding short-term risk, NTRBW is more volatile compared to APLS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check APLS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CRSP has a market cap of 5.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CRSP trades at $53.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CRSP's P/E ratio is -11.23. In terms of profitability, NTRBW's ROE is -1.09%, compared to CRSP's ROE of -0.24%. Regarding short-term risk, NTRBW is more volatile compared to CRSP. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CRSP's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, DFTX has a market cap of 5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while DFTX trades at $37.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas DFTX's P/E ratio is N/A. In terms of profitability, NTRBW's ROE is -1.09%, compared to DFTX's ROE of -0.85%. Regarding short-term risk, NTRBW is more volatile compared to DFTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check DFTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TERN has a market cap of 4.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TERN trades at $52.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TERN's P/E ratio is -51.41. In terms of profitability, NTRBW's ROE is -1.09%, compared to TERN's ROE of -0.20%. Regarding short-term risk, NTRBW is more volatile compared to TERN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TERN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ACAD has a market cap of 4.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ACAD trades at $27.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ACAD's P/E ratio is 12.47. In terms of profitability, NTRBW's ROE is -1.09%, compared to ACAD's ROE of +0.32%. Regarding short-term risk, NTRBW is more volatile compared to ACAD. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ACAD's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, EWTX has a market cap of 4.7B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while EWTX trades at $43.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas EWTX's P/E ratio is -23.45. In terms of profitability, NTRBW's ROE is -1.09%, compared to EWTX's ROE of -0.39%. Regarding short-term risk, NTRBW is more volatile compared to EWTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check EWTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while FOLD trades at $14.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas FOLD's P/E ratio is -161.00. In terms of profitability, NTRBW's ROE is -1.09%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, NTRBW is more volatile compared to FOLD. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check FOLD's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PBLS has a market cap of 4.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PBLS trades at $38.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PBLS's P/E ratio is -44.05. In terms of profitability, NTRBW's ROE is -1.09%, compared to PBLS's ROE of -0.15%. Regarding short-term risk, NTRBW is more volatile compared to PBLS. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PBLS's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while AKRO trades at $54.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas AKRO's P/E ratio is -14.57. In terms of profitability, NTRBW's ROE is -1.09%, compared to AKRO's ROE of -0.22%. Regarding short-term risk, NTRBW is more volatile compared to AKRO. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check AKRO's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ALPN trades at $64.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ALPN's P/E ratio is -101.52. In terms of profitability, NTRBW's ROE is -1.09%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, NTRBW is more volatile compared to ALPN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ALPN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CELC has a market cap of 4.4B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CELC trades at $90.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CELC's P/E ratio is -20.95. In terms of profitability, NTRBW's ROE is -1.09%, compared to CELC's ROE of -3.51%. Regarding short-term risk, NTRBW is more volatile compared to CELC. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CELC's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while OPT trades at $3.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas OPT's P/E ratio is -1.52. In terms of profitability, NTRBW's ROE is -1.09%, compared to OPT's ROE of +1.18%. Regarding short-term risk, NTRBW is more volatile compared to OPT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check OPT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, PRTC has a market cap of 4.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while PRTC trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas PRTC's P/E ratio is -3.78. In terms of profitability, NTRBW's ROE is -1.09%, compared to PRTC's ROE of -0.32%. Regarding short-term risk, NTRBW is more volatile compared to PRTC. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check PRTC's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TLX has a market cap of 4.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TLX trades at $12.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TLX's P/E ratio is 128.81. In terms of profitability, NTRBW's ROE is -1.09%, compared to TLX's ROE of +0.07%. Regarding short-term risk, NTRBW is more volatile compared to TLX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TLX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MANE has a market cap of 4.2B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MANE trades at $99.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MANE's P/E ratio is -31.76. In terms of profitability, NTRBW's ROE is -1.09%, compared to MANE's ROE of -0.38%. Regarding short-term risk, NTRBW is more volatile compared to MANE. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MANE's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while MRTX trades at $58.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas MRTX's P/E ratio is -4.82. In terms of profitability, NTRBW's ROE is -1.09%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, NTRBW is more volatile compared to MRTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check MRTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ELVN has a market cap of 4.1B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ELVN trades at $57.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ELVN's P/E ratio is -34.40. In terms of profitability, NTRBW's ROE is -1.09%, compared to ELVN's ROE of -0.19%. Regarding short-term risk, NTRBW is more volatile compared to ELVN. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ELVN's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RLAY has a market cap of 4.1B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RLAY trades at $18.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RLAY's P/E ratio is -11.89. In terms of profitability, NTRBW's ROE is -1.09%, compared to RLAY's ROE of -0.42%. Regarding short-term risk, NTRBW is more volatile compared to RLAY. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RLAY's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, ADPT has a market cap of 3.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while ADPT trades at $24.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas ADPT's P/E ratio is -59.56. In terms of profitability, NTRBW's ROE is -1.09%, compared to ADPT's ROE of -0.33%. Regarding short-term risk, NTRBW is more volatile compared to ADPT. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check ADPT's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, TNGX has a market cap of 3.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while TNGX trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas TNGX's P/E ratio is -28.92. In terms of profitability, NTRBW's ROE is -1.09%, compared to TNGX's ROE of -0.26%. Regarding short-term risk, NTRBW is more volatile compared to TNGX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check TNGX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, CPRX has a market cap of 3.9B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while CPRX trades at $31.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas CPRX's P/E ratio is 12.30. In terms of profitability, NTRBW's ROE is -1.09%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, NTRBW is more volatile compared to CPRX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check CPRX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, VKTX has a market cap of 3.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while VKTX trades at $32.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas VKTX's P/E ratio is -7.02. In terms of profitability, NTRBW's ROE is -1.09%, compared to VKTX's ROE of -0.95%. Regarding short-term risk, NTRBW is more volatile compared to VKTX. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check VKTX's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, IOVA has a market cap of 3.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while IOVA trades at $8.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas IOVA's P/E ratio is -11.55. In terms of profitability, NTRBW's ROE is -1.09%, compared to IOVA's ROE of -0.41%. Regarding short-term risk, NTRBW is more volatile compared to IOVA. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check IOVA's competition here

Nutriband Inc. (NASDAQ: NTRBW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NTRBW stands at 27.3M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, NTRBW is priced at $0.20 on the NASDAQ, while RYZB trades at $62.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NTRBW currently has a P/E ratio of -0.08, whereas RYZB's P/E ratio is -57.86. In terms of profitability, NTRBW's ROE is -1.09%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, NTRBW is more volatile compared to RYZB. This indicates higher risk in terms of short-term price fluctuations for NTRBW.Check RYZB's competition here